In brain cancer, low expression of classical HLA class I genes (HLA-A, -B, and –C) [36] coupled with up-regulation of nonclassical genes (e.g., HLA-E and HLA-G) likely contributes to immune escape by tumor cells with various somatic mutations [37]–[39]. The gene discussed is HLA-E; the disease is neoplasm.